Planning Strategies Inc.’s AbbVie ABBV Stock Holding History

Planning Strategies Inc.’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	+1,001	New	+$215K	0.16%	58

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Planning Strategies Inc.'s ABBV Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in AbbVie (ABBV) in Q2 2026: 1,001 shares worth $252K. The stake represents 0.16% of the portfolio and ranks #58 among its holdings.

1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Planning Strategies Inc. held 1,001 shares of AbbVie worth $252K as of Q2 2026.
AbbVie was a new Planning Strategies Inc. position in Q2 2026.
AbbVie made up 0.16% of Planning Strategies Inc.'s portfolio in Q2 2026, its #58 holding.
1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.